These results confirm the high gene expression inhibitory activity of B-ASO nanostructures 1/2 directed towards endogenous mRNA of EGFR in the A431 tumor cell line, higher than that of the non-modified ASO-22. The gene discussed is EGFR; the disease is neoplasm.